New Biosensor Detects COVID-19 Virus in Air
By HospiMedica International staff writers Posted on 25 Apr 2020 |

Image: New biosensor detects COVID-19 virus in air (Photo courtesy of Fusion Medical Animation)
A team of researchers from Switzerland has succeeded in developing a novel sensor for detecting the new coronavirus that could be used to measure the concentration of the virus in the environment, such as in places where there are many people or in hospital ventilation systems.
The researchers from Empa (Zürich, Switzerland) and ETH Zurich (Zürich, Switzerland) usually work on measuring, analyzing and reducing airborne pollutants such as aerosols and artificially produced nanoparticles. However, the COVID-19 challenge being faced by the whole world made the team shift its focus to developing a sensor that can quickly and reliably detect SARS-CoV-2 - the new coronavirus. Even before the COVID-19 began to spread, the team was researching sensors that could detect bacteria and viruses in the air and in early January, it came up with the idea of using this basis to further develop the sensor in such a way that it could reliably identify a specific virus was born. The sensor would not necessarily replace the established laboratory tests, but could be used as an alternative method for clinical diagnosis, and more prominently to measure the virus concentration in the air in real time, such as in busy places like train stations or hospitals.
As opposed to the molecular method called reverse transcription polymerase chain reaction, or RT-PCR for short, used in labs to detect viruses in respiratory infections, the researchers have developed an alternative test method in the form of an optical biosensor. The sensor combines two different effects to detect the virus safely and reliably: an optical and a thermal one. The sensor is based on tiny structures of gold, so-called gold nanoislands, on a glass substrate. Artificially produced DNA receptors that match specific RNA sequences of the SARS-CoV-2 are grafted onto the nanoislands. The receptors on the sensor are the complementary sequences to the virus' unique RNA sequences, which can reliably identify the virus.
To demonstrate how reliably the new sensor detects the current COVID-19 virus, the researchers tested it with a very closely related virus: SARS-CoV which broke out in 2003 and triggered the SARS pandemic. The validation was successful although a number of developmental steps are still needed to enable the sensor to measure the coronavirus concentration in the air.
“Tests showed that the sensor can clearly distinguish between the very similar RNA sequences of the two viruses,” said Jing Wang, one of the researchers. “This still needs development work. But once the sensor is ready, the principle could be applied to other viruses and help to detect and stop epidemics at an early stage.”
Related Links:
Empa
ETH Zurich
The researchers from Empa (Zürich, Switzerland) and ETH Zurich (Zürich, Switzerland) usually work on measuring, analyzing and reducing airborne pollutants such as aerosols and artificially produced nanoparticles. However, the COVID-19 challenge being faced by the whole world made the team shift its focus to developing a sensor that can quickly and reliably detect SARS-CoV-2 - the new coronavirus. Even before the COVID-19 began to spread, the team was researching sensors that could detect bacteria and viruses in the air and in early January, it came up with the idea of using this basis to further develop the sensor in such a way that it could reliably identify a specific virus was born. The sensor would not necessarily replace the established laboratory tests, but could be used as an alternative method for clinical diagnosis, and more prominently to measure the virus concentration in the air in real time, such as in busy places like train stations or hospitals.
As opposed to the molecular method called reverse transcription polymerase chain reaction, or RT-PCR for short, used in labs to detect viruses in respiratory infections, the researchers have developed an alternative test method in the form of an optical biosensor. The sensor combines two different effects to detect the virus safely and reliably: an optical and a thermal one. The sensor is based on tiny structures of gold, so-called gold nanoislands, on a glass substrate. Artificially produced DNA receptors that match specific RNA sequences of the SARS-CoV-2 are grafted onto the nanoislands. The receptors on the sensor are the complementary sequences to the virus' unique RNA sequences, which can reliably identify the virus.
To demonstrate how reliably the new sensor detects the current COVID-19 virus, the researchers tested it with a very closely related virus: SARS-CoV which broke out in 2003 and triggered the SARS pandemic. The validation was successful although a number of developmental steps are still needed to enable the sensor to measure the coronavirus concentration in the air.
“Tests showed that the sensor can clearly distinguish between the very similar RNA sequences of the two viruses,” said Jing Wang, one of the researchers. “This still needs development work. But once the sensor is ready, the principle could be applied to other viruses and help to detect and stop epidemics at an early stage.”
Related Links:
Empa
ETH Zurich
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans
Channels
Critical Care
view channel
Ingestible Smart Capsule for Chemical Sensing in the Gut Moves Closer to Market
Intestinal gases are associated with several health conditions, including colon cancer, irritable bowel syndrome, and inflammatory bowel disease, and they have the potential to serve as crucial biomarkers... Read more
Novel Cannula Delivery System Enables Targeted Delivery of Imaging Agents and Drugs
Multiphoton microscopy has become an invaluable tool in neuroscience, allowing researchers to observe brain activity in real time with high-resolution imaging. A crucial aspect of many multiphoton microscopy... Read more
Novel Intrabronchial Method Delivers Cell Therapies in Critically Ill Patients on External Lung Support
Until now, administering cell therapies to patients on extracorporeal membrane oxygenation (ECMO)—a life-support system typically used for severe lung failure—has been nearly impossible.... Read moreSurgical Techniques
view channel
Pioneering Sutureless Coronary Bypass Technology to Eliminate Open-Chest Procedures
In patients with coronary artery disease, certain blood vessels may be narrowed or blocked, requiring a stent or a bypass (also known as diversion) to restore blood flow to the heart. Bypass surgeries... Read more
Intravascular Imaging for Guiding Stent Implantation Ensures Safer Stenting Procedures
Patients diagnosed with coronary artery disease, which is caused by plaque accumulation within the arteries leading to chest pain, shortness of breath, and potential heart attacks, frequently undergo percutaneous... Read more
World's First AI Surgical Guidance Platform Allows Surgeons to Measure Success in Real-Time
Surgeons have always faced challenges in measuring their progress toward surgical goals during procedures. Traditionally, obtaining measurements required stepping out of the sterile environment to perform... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Expanded Collaboration to Transform OR Technology Through AI and Automation
The expansion of an existing collaboration between three leading companies aims to develop artificial intelligence (AI)-driven solutions for smart operating rooms with sophisticated monitoring and automation.... Read more